No Data
Conduit Pharmaceuticals Receives Further Patent Approval For Lead Asset Targeting Autoimmune Disorders
12 Health Care Stocks Moving In Thursday's Pre-Market Session
What's Going On With Conduit Pharmaceuticals Shares Today?
Conduit Pharmaceuticals Shares Are Trading Higher After the Company Announced That the Japan Patent Office Granted a Composition of Matter Patent for Its Lead Asset, AZD1656.
Express News | Conduit Pharmaceuticals Shares Are Trading Higher After the Company Announced That the Japan Patent Office Granted a Composition of Matter Patent for Its Lead Asset, AZD1656
Conduit Pharmaceuticals Receives Further Patent Approval for AZD1656
No Data
No Data
![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined"){kind=small}
